HealthMore in Health→
GLP-1 Drugs Like Ozempic Linked to Lower Risk of Substance Use Disorders, Study Finds
Key Takeaways
- UTEP study of 142,000 patients found GLP-1 users had 74% lower alcohol use disorder odds, 69% lower opioid, 68% lower nicotine, and 75% lower cocaine use disorder odds.
- Researchers caution the observational study does not prove causation; randomized trials are needed before prescribing GLP-1s for addiction.
- GLP-1s may affect dopamine signaling and reward pathways, potentially reducing cravings for substances beyond food.
DE
DT Editorial Team··via medicalxpress.com
